ProfessionalHybridNo New Dates

EMBARK OPEN Access

EMBARK Open Access is a comprehensive course designed to equip care providers with the skills and knowledge to provide ethical, culturally competent, and trauma-informed psychedelic facilitation.

Provider

Cybin

English

Schedule

25 years

Enrollment

Free

Decision Summary

Best fit
Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.
Format
Hybrid
Time commitment
25 years
Credential signal
The model has been published in Frontiers in Psychology.
Delivery
Online

Course Overview

EMBARK Open Access (OA) is a comprehensive course designed to equip care providers with the skills and knowledge to provide ethical, culturally competent, and trauma-informed psychedelic facilitation. Based on the innovative EMBARK model, which combines elements from over a dozen previous approaches, this course focuses on six clinical domains and four care cornerstones that ensure effective therapeutic support within a broader framework of collective caregiving.

The EMBARK Training Program offers a blended model of live and self-guided activities, preparing participants to become Certified EMBARK Facilitators. The curriculum includes didactics, experiential activities, group discussions, independent study, and clinical supervision, led by a team of 28 faculty members, supervisors, and advisors. EMBARK's creators, Bill Brennan, PhD, and Alex Belser, PhD, have developed the program based on process evidence in psychedelic clinical practice and the experiences of senior teachers and supervisors.

The EMBARK model has been published in the peer-reviewed journal Frontiers in Psychology and can be adapted to different clinical indications and problems, such as depression, alcohol use disorder, and anxiety. With its transdiagnostic treatment model and commitment to accessibility, EMBARK Open Access aims to revolutionize mental healthcare by providing innovative psychedelic-based treatment options.

Who is this for?

Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.

About the Provider

Cybin Inc. (founded 2019) is a Canadian clinical-stage biopharmaceutical company developing psychedelic-based therapeutics—now operating as Helus Pharma—focused on proprietary novel serotonergic agonists and deuterated psilocin analogs for mental health conditions.

Course FAQ

Who is this course for?

Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.

What is the format and time commitment?

Format: Hybrid. Time commitment: 25 years.

How much does it cost?

The listed price is $0. Confirm the latest tuition, fees, and payment options with [object Object].

Does it offer a certificate or CE/CME credit?

Accreditation note: The model has been published in Frontiers in Psychology.. Confirm credential eligibility directly with the provider before enrolling.

Is this course currently available?

The current listing status is No New Dates. Use the provider website for the latest enrollment status.

Related Courses

View all courses